Fabio Ferrando

683 total citations
23 papers, 398 citations indexed

About

Fabio Ferrando is a scholar working on Oncology, Hematology and Molecular Biology. According to data from OpenAlex, Fabio Ferrando has authored 23 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Hematology and 7 papers in Molecular Biology. Recurrent topics in Fabio Ferrando's work include Hematopoietic Stem Cell Transplantation (6 papers), Neutropenia and Cancer Infections (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Fabio Ferrando is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Neutropenia and Cancer Infections (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). Fabio Ferrando collaborates with scholars based in Italy, Qatar and United States. Fabio Ferrando's co-authors include Alberto Ballestrero, Franco Patrone, Franco Dallegri, Luciano Ottonello, C. Sacchetti, Riccardo Ghio, Patrizia Dapino, Mario Sessarego, Fulvio Brema and Anna Garuti and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Fabio Ferrando

22 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fabio Ferrando Italy	12	161	104	96	86	44	23	398
Darlene J. Elias United States	13	106 0.7×	150 1.4×	97 1.0×	78 0.9×	40 0.9×	28	503
Valerie Relias United States	11	161 1.0×	139 1.3×	72 0.8×	182 2.1×	27 0.6×	32	463
Anna Szmigielska‐Kapłon Poland	16	151 0.9×	198 1.9×	215 2.2×	103 1.2×	21 0.5×	55	570
M. Westerhausen Germany	11	212 1.3×	116 1.1×	73 0.8×	53 0.6×	24 0.5×	50	428
Roland Conradi Germany	8	70 0.4×	61 0.6×	171 1.8×	107 1.2×	23 0.5×	13	448
Kenji Bannai Japan	7	110 0.7×	122 1.2×	38 0.4×	78 0.9×	27 0.6×	12	378
Shigeru Tsuyuki Japan	10	163 1.0×	79 0.8×	45 0.5×	73 0.8×	18 0.4×	32	378
G Mathé France	9	170 1.1×	120 1.2×	69 0.7×	37 0.4×	37 0.8×	48	386
Koji Takasugi Japan	6	73 0.5×	198 1.9×	37 0.4×	103 1.2×	29 0.7×	12	394
Ramzi Abboud United States	9	173 1.1×	176 1.7×	227 2.4×	134 1.6×	49 1.1×	28	527

Countries citing papers authored by Fabio Ferrando

Since Specialization

Citations

This map shows the geographic impact of Fabio Ferrando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabio Ferrando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabio Ferrando more than expected).

Fields of papers citing papers by Fabio Ferrando

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabio Ferrando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabio Ferrando. The network helps show where Fabio Ferrando may publish in the future.

Co-authorship network of co-authors of Fabio Ferrando

This figure shows the co-authorship network connecting the top 25 collaborators of Fabio Ferrando. A scholar is included among the top collaborators of Fabio Ferrando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabio Ferrando. Fabio Ferrando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cirmena, Gabriella, Lorenzo Ferrando, Anna Garuti, et al.. (2021). Abstract LB063: Plasma cell-free DNA integrity predicts the achievement of pathological complete response to neoadjuvant chemotherapy in breast cancer patients. Cancer Research. 81(13_Supplement). LB063–LB063. 1 indexed citations

Furfaro, Elisa, Laura Ambra Nicolini, Carmen Di Grazia, et al.. (2020). Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and Infection. Biology of Blood and Marrow Transplantation. 26(7). 1355–1362. 11 indexed citations

Cirmena, Gabriella, Anna Garuti, Marilena De Mariano, et al.. (2020). Circulating Tumor DNA Using Tagged Targeted Deep Sequencing to Assess Minimal Residual Disease in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy. Journal of Oncology. 2020. 1–10. 3 indexed citations

Isnaldi, Edoardo, Domenico Ferraioli, Lorenzo Ferrando, et al.. (2019). Schlafen-11 expression is associated with immune signatures and basal-like phenotype in breast cancer. Breast Cancer Research and Treatment. 177(2). 335–343. 24 indexed citations

Demarzo, Maria Giulia, Gaia Pellegatta, Fabio Ferrando, et al.. (2018). Improvement in Waldenström’s Macroglobulinemia after Successful Treatment of HCV with Direct-acting Antivirals. Annals of Hepatology. 17(6). 1072–1077.

Carbone, Federico, Marta Bovio, Gian Marco Rosa, et al.. (2014). Inferior vena cava parameters predict re‐admission in ischaemic heart failure. European Journal of Clinical Investigation. 44(4). 341–349. 21 indexed citations

Zoppoli, Gabriele, Michele Cea, Debora Soncini, et al.. (2010). Potent synergistic interaction between the Nampt inhibitor APO866 and the apoptosis activator TRAIL in human leukemia cells. Experimental Hematology. 38(11). 979–988. 41 indexed citations

Ballestrero, Alberto, Fabio Ferrando, Maurizio Miglino, et al.. (2002). Three‐step high‐dose sequential chemotherapy in patients with newly diagnosed multiple myeloma. European Journal Of Haematology. 68(2). 101–106. 4 indexed citations

Ballestrero, Alberto, Domenico Coviello, Anna Garuti, et al.. (2001). Reverse-transcriptase polymerase chain reaction of the maspin gene in the detection of bone marrow breast carcinoma cell contamination. Cancer. 92(8). 2030–2035. 18 indexed citations

10.

Ballestrero, Alberto, A. Rubagotti, Fabio Ferrando, et al.. (2001). Adjuvant Chemotherapy with High-Dose Cyclophosphamide, Etoposide and Cisplatin Intensification without Progenitor Cell Support in Breast Cancer Patients with Ten or More Involved Nodes: 5-Year Results of a Pilot Trial. Oncology. 60(3). 221–227. 2 indexed citations

11.

Balleari, Enrico, Giuseppe Villa, Marco Carletto, et al.. (2001). Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.. PubMed. 86(1). 78–84. 26 indexed citations

12.

Ballestrero, Alberto, Fabio Ferrando, Anna Garuti, et al.. (2000). Effects of Three Cytokine Regimens on Hematologic Recovery and Progenitor Cell Mobilization after High-Dose Cyclophosphamide, Etoposide, and Cisplatin. Oncology. 59(1). 7–13. 3 indexed citations

13.

Setti, Maurizio, Donatella Bignardi, Alberto Ballestrero, et al.. (1999). The induction of distinct cytokine cascades correlates with different effects of granulocyte-colony stimulating factor and granulocyte/macrophage-colony-stimulating factor on the lymphocyte compartment in the course of high-dose chemotherapy for breast cancer. Cancer Immunology Immunotherapy. 48(6). 287–296. 9 indexed citations

14.

Ballestrero, Alberto, Fabio Ferrando, Anna Garuti, et al.. (1999). Comparative Effects of Three Cytokine Regimens After High-Dose Cyclophosphamide: Granulocyte Colony-Stimulating Factor, Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF), and Sequential Interleukin-3 and GM-CSF. Journal of Clinical Oncology. 17(4). 1296–1296. 18 indexed citations

15.

Ballestrero, Alberto, Fabio Ferrando, Anna Garuti, et al.. (1997). High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule. British Journal of Cancer. 76(6). 797–804. 12 indexed citations

16.

Ballestrero, Alberto, et al.. (1997). Standard-Dose Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) Allows Safe and Repeated Administration of High-Dose Cyclophosphamide, Etoposide, and Cisplatin (CEP). American Journal of Clinical Oncology. 20(3). 266–271. 3 indexed citations

17.

Amoroso, D., Francesco Boccardo, A. Rubagotti, et al.. (1997). 0-28. Adjuvant high dose chemotherapy (HD CT) without bone marrow rescue in breast cancer patients (b.c. pts) with 10 or more positive nodes (N ≥ 10): preliminary results of an Italian breast cancer adjuvant study group (GROCTA) trial. The Breast. 6(4). 232–232. 1 indexed citations

18.

Patrone, Franco, Alberto Ballestrero, Fabio Ferrando, et al.. (1995). Four-step high-dose sequential chemotherapy with double hematopoietic progenitor-cell rescue for metastatic breast cancer.. Journal of Clinical Oncology. 13(4). 840–846. 30 indexed citations

19.

Dallegri, Franco, Luciano Ottonello, Alberto Ballestrero, et al.. (1991). Tumor cell lysis by activated human neutrophils: Analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. Inflammation. 15(1). 15–30. 58 indexed citations

20.

Dallegri, Franco, et al.. (1990). Cytoprotection against neutrophil derived hypochlorous acid: a potential mechanism for the therapeutic action of 5-aminosalicylic acid in ulcerative colitis.. Gut. 31(2). 184–186. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact